Several reports indicate that BIRC2 gene expression is upregulated in multiple types of cancers and that overexpression of BIRC2 counteracts apoptosis and increases the resistance of tumor cells to chemotherapy and immunotherapy [24, 42, 43]. Here, BIRC2 is linked to cancer.